Central African Republic vs Paraguay: Access to anti-retroviral drugs, male
Central African Republic
61.0%
in 2024
Paraguay
61.0%
in 2024
Central African Republic rank
97th
Paraguay rank
97th
Access to anti-retroviral drugs, male over time
- Central African Republic
- Paraguay
How they compare
Central African Republic currently reports 61.0% against 61.0% in Paraguay, a difference of 0.0%.
Across all 25 years both countries report, Paraguay has been ahead every year.
Central African Republic ranks 97th and Paraguay ranks 97th of 141 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.2% | 6.4% | 3.2% | Paraguay |
| 2010s | 24.1% | 34.0% | 9.9% | Paraguay |
| 2020s | 53.0% | 56.2% | 3.2% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Central African Republic or Paraguay?
- Central African Republic, at 61.0% against 61.0% in Paraguay as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Central African Republic and Paraguay?
- 0.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Paraguay?
- 25 years are reported by both, from 2000 to 2024.
- How do Central African Republic and Paraguay rank globally for access to anti-retroviral drugs, male?
- Central African Republic ranks 97th and Paraguay ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.